These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16403096)

  • 21. Dissecting the associations of endemic pemphigus foliaceus (Fogo Selvagem) with HLA-DRB1 alleles and genotypes.
    Pavoni DP; Roxo VM; Marquart Filho A; Petzl-Erler ML
    Genes Immun; 2003 Mar; 4(2):110-6. PubMed ID: 12618858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraperitoneal injection of pemphigus vulgaris-IgG into mouse depletes epidermal keratinocytes of desmoglein 3 associated with generation of acantholysis.
    Shu E; Yamamoto Y; Aoyama Y; Kitajima Y
    Arch Dermatol Res; 2007 Jun; 299(3):165-7. PubMed ID: 17431647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Family study of monozygotic twins affected by pemphigus vulgaris.
    Salathiel AM; Brochado MJ; Kim O; Deghaide NH; Donadi EA; Roselino AM
    Hum Immunol; 2016 Jul; 77(7):600-4. PubMed ID: 27177496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pemphigus foliaceus and desmoglein 1 gene polymorphism: is there any relationship?
    Petzl-Erler ML; Malheiros D
    J Autoimmun; 2005 Sep; 25(2):121-5. PubMed ID: 16242304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose pemphigus antibodies against linear epitopes of desmoglein 3 (Dsg3) can induce acantholysis and depletion of Dsg3 from keratinocytes.
    Cirillo N; Femiano F; Gombos F; Lanza A
    Immunol Lett; 2009 Feb; 122(2):208-13. PubMed ID: 19200441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral mucosal disease: pemphigus.
    Scully C; Mignogna M
    Br J Oral Maxillofac Surg; 2008 Jun; 46(4):272-7. PubMed ID: 17870218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of anti-desmoglein antibodies and indirect immunofluorescence in the serodiagnosis of pemphigus vulgaris.
    Zagorodniuk I; Weltfriend S; Shtruminger L; Sprecher E; Kogan O; Pollack S; Bergman R
    Int J Dermatol; 2005 Jul; 44(7):541-4. PubMed ID: 15985020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-junctional human desmoglein 3 acts as an upstream regulator of Src in E-cadherin adhesion, a pathway possibly involved in the pathogenesis of pemphigus vulgaris.
    Tsang SM; Brown L; Lin K; Liu L; Piper K; O'Toole EA; Grose R; Hart IR; Garrod DR; Fortune F; Wan H
    J Pathol; 2012 May; 227(1):81-93. PubMed ID: 22294297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Confirmation of a disease model of pemphigus vulgaris: characterization and correlation between disease parameters in 90 mice.
    Holm TL; Markholst H
    Exp Dermatol; 2010 Aug; 19(8):e158-65. PubMed ID: 20201956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenic human monoclonal antibody against desmoglein 3.
    Yeh SW; Cavacini LA; Bhol KC; Lin MS; Kumar M; Duval M; Posner MR; Ahmed AR
    Clin Immunol; 2006 Jul; 120(1):68-75. PubMed ID: 16635589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pemphigus mouse model as a tool to evaluate various immunosuppressive therapies.
    Takae Y; Nishikawa T; Amagai M
    Exp Dermatol; 2009 Mar; 18(3):252-60. PubMed ID: 18643850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcellular localization of desmosomal components is different between desmoglein3 knockout mice and pemphigus vulgaris model mice.
    Saito H; Shimizu A; Tsunoda K; Amagai M; Ishiko A
    J Dermatol Sci; 2009 Aug; 55(2):108-15. PubMed ID: 19525093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of desmoglein-3 peptides reveals multiple shared T-cell epitopes in HLA DR4- and DR6-associated pemphigus vulgaris.
    Tong JC; Tan TW; Sinha AA; Ranganathan S
    BMC Bioinformatics; 2006 Dec; 7 Suppl 5(Suppl 5):S7. PubMed ID: 17254312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of low avidity desmoglein 3-reactive T cells in pemphigus vulgaris using HLA-DR beta 1*0402 tetramers.
    Veldman C; Eming R; Wolff-Franke S; Sonderstrup G; Kwok WW; Hertl M
    Clin Immunol; 2007 Mar; 122(3):330-7. PubMed ID: 17113829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No activation of urokinase plasminogen activator by anti-desmoglein 3 monoclonal IgG antibodies in cultured human keratinocytes.
    Yamamoto Y; Aoyama Y; Shu E; Tsunoda K; Amagai M; Kitajima Y
    J Dermatol Sci; 2007 Aug; 47(2):119-25. PubMed ID: 17532189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recognition of desmoglein 3 by autoreactive T cells in pemphigus vulgaris patients and normals.
    Hertl M; Amagai M; Sundaram H; Stanley J; Ishii K; Katz SI
    J Invest Dermatol; 1998 Jan; 110(1):62-6. PubMed ID: 9424089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumour necrosis factor-alpha single nucleotide polymorphisms are not independent of HLA class I in UK Caucasians with adult onset idiopathic inflammatory myopathies.
    Chinoy H; Salway F; John S; Fertig N; Tait BD; Oddis CV; Ollier WE; Cooper RG;
    Rheumatology (Oxford); 2007 Sep; 46(9):1411-6. PubMed ID: 17586554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Number II. Pemphigus vulgaris.
    Black M; Mignogna MD; Scully C
    Oral Dis; 2005 May; 11(3):119-30. PubMed ID: 15888101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA class II antigens in Croatian patients with pemphigus vulgaris and their correlation with anti-desmoglein antibodies.
    Lakoš Jukić I; Mokos M; Marinović B
    Front Immunol; 2023; 14():1200992. PubMed ID: 37529044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of sensitivity and specificity of enzyme-linked immunosorbent assay (ELISA) for detecting antidesmoglein 1 and 3 in Thai patients with pemphigus vulgaris and foliaceus.
    Kulkollakarn S; Wattanakrai P; Vachiramon V; Chalidapongse P
    J Med Assoc Thai; 2008 Nov; 91(11):1663-8. PubMed ID: 19127786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.